Literature DB >> 9068590

Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma.

Y Ishikawa1, J E Saffitz, T L Mealman, A M Grace, R Roberts.   

Abstract

Creatine kinase (CK) isoenzymes MM, MB, and BB are located primarily in the cell cytosol, and increased CKMB in plasma is the hallmark of myocardial infarction. However, whether CK is released with reversible ischemic injury remains controversial. Here, we assessed plasma CK activity--cytosolic and mitochondrial CK--in serial samples (every 10 min for 60 min, then hourly or every 4 h for 48 h) from 46 conscious dogs after transient or sustained coronary occlusion. Four dogs were sham-operated (controls); four underwent sustained coronary occlusion (96 h); and 38 underwent transient coronary occlusion (10-40 min) followed by 48 h of reperfusion. In postmortem histological examination of the dogs' hearts by light and electron microscopy, we looked for ischemia or necrosis. The presence of cell swelling and glycogen depletion was indicative of ischemia, whereas the added presence of cell disruption indicated necrosis. Coronary occlusion for > or = 20 min consistently increased plasma mitochondrial and total CK activity and produced histologically evident myocardial necrosis. In contrast, after 10 to 15 min of coronary occlusion, 12 of 14 animals, despite extensive severe reversible ischemia, showed no increase in plasma CK; the remaining 2, which had increased plasma CK, had subendocardial necrosis. Thus, cytosolic or mitochondrial CK is released from the heart only when there has been irreversible myocardial injury-a finding with significant diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068590

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Molecular biology of heart disease.

Authors:  Robert Roberts
Journal:  World J Cardiol       Date:  2011-04-26

2.  Biochemical advances in detection of the acute coronary syndromes: Implications for therapeutic decisions.

Authors:  J H Keffer
Journal:  Indian J Clin Biochem       Date:  1999-01

Review 3.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

Review 4.  Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling.

Authors:  John M Canty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-05-13       Impact factor: 5.125

5.  Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging. Delayed enhancement and routine clinical parameters after myocardial infarction.

Authors:  Steffen E Petersen; Georg Horstick; Thomas Voigtländer; Karl-Friedrich Kreitner; Thomas Wittlinger; Steffen Ziegler; Nico Abegunewardene; Melanie Schmitt; Wolfgang G Schreiber; Peter Kalden; Oliver K Mohrs; Manfred Thelen; Juergen Meyer
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

6.  The effects of heart and skeletal muscle inflammation and cardiomyopathy syndrome on creatine kinase and lactate dehydrogenase levels in Atlantic salmon (Salmo salar L.).

Authors:  Muhammad Naveed Yousaf; Mark D Powell
Journal:  ScientificWorldJournal       Date:  2012-05-22

7.  Histological evidence for reversible cardiomyocyte changes and serum cardiac troponin T elevation after exercise in rats.

Authors:  Jinlei Nie; Keith George; Fei Duan; Tomas K Tong; Ye Tian
Journal:  Physiol Rep       Date:  2016-12

Review 8.  Post-Myocardial Infarction Ventricular Remodeling Biomarkers-The Key Link between Pathophysiology and Clinic.

Authors:  Maria-Madălina Bostan; Cristian Stătescu; Larisa Anghel; Ionela-Lăcrămioara Șerban; Elena Cojocaru; Radu Sascău
Journal:  Biomolecules       Date:  2020-11-23

9.  Another Unanswerable Question.

Authors:  Allan S Jaffe
Journal:  JACC Basic Transl Sci       Date:  2017-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.